BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 20, 2021
View Archived Issues
Mutations in TP73 cause lissencephaly and impaired mucociliary clearance
Read More
YishengBio cleared in UAE to conduct phase I study of PIKA recombinant COVID-19 vaccine
Read More
MUSK-targeting agonist antibody is protective against experimental congenital myasthenia
Read More
Kymera Therapeutics STAT3 degradation inducers demonstrate preclinical activity
Read More
Sumitomo Dainippon Pharma divulges 5-HT2A and/or 5-HT7 receptor antagonists
Read More
Positive topline data reported from phase II REDWOOD-HCM study of CK-274
Read More
Sitryx Therapeutics presents new NFE2L2 activators
Read More
Angex Pharmaceutical synthesizes new mTOR inhibitors
Read More
SRI International describes lipoxygenase inhibitors
Read More
iOnctura initiates clinical development of next-generation autotaxin inhibitor IOA-289
Read More
DSMB recommends continued treatment in phase II portion of OVATION 2 study with GEN-1
Read More
Prometheus initiates phase II ARTEMIS-UC study of PRA-023
Read More
Loss-of-function variant in SUV39H2 identified in autism spectrum disorder
Read More
VX-548 enters phase II development for the treatment of acute pain
Read More
CXCL9 levels predict future cardiac aging and vascular dysfunction
Read More
GS-9822 retargets integration sites and induces deep latent state in vitro
Read More
Modulation of STAT pathway with HODHBt improves NK cell cytotoxicity
Read More
Acumen initiates phase I study of ACU-193 in mild cognitive impairment or mild Alzheimer's
Read More
Lenacapavir confers viral suppression by week 16 in HIV-infected patients
Read More
Grant supports clinical development of ISA-104 for chronic hepatitis B
Read More